SCHEMBL6786104

SCHEMBL6786104

Cn1ncc2nc3ccc(Cc4ccccc4)cc3c(Cl)c21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.46
CYP2C19 P33261 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HIF1A Q16665 1/20 0.46
EGLN1 Q9GZT9 6/20 0.40
RORC P51449 2/20 0.39
CCNC P24863 1/20 0.37
CDK8 P49336 1/20 0.37
ALDH1A1 P00352 3/20 0.37
CYP1A2 P05177 3/20 0.37
MAPT P10636 3/20 0.37
HPGD P15428 2/20 0.37
HSD17B10 Q99714 1/20 0.37
BRD4 O60885 1/20 0.37
KAT2B Q92831 1/20 0.37
BRD9 Q9H8M2 1/20 0.37
GAA P10253 1/20 0.37
PKM P14618 1/20 0.37
RAB9A P51151 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6784794 0.92 CYP3A4 (0.46) CYP3A4CYP2C19KDM4EHIF1ARORC
SCHEMBL6786326 0.91 PDE2A (0.42) CYP3A4CYP2C19KDM4EHIF1ARORC
SCHEMBL6781552 0.90 CYP3A4 (0.44) CYP3A4CYP2C19KDM4EHIF1AEGLN1
SCHEMBL6784323 0.89 CYP3A4 (0.39) CYP3A4CYP2C19KDM4EHIF1ARORC
SCHEMBL6785449 0.88 TUBB4A (0.46) CYP3A4CYP2C19KDM4EHIF1ARORC
SCHEMBL6781849 0.88 PDE2A (0.38) CYP3A4CYP2C19KDM4EHIF1ARORC
SCHEMBL6786439 0.87 LTB4R (0.43) CYP3A4CYP2C19KDM4EHIF1A
SCHEMBL6786756 0.87 KDM4E (0.41) CYP3A4CYP2C19KDM4EHIF1ARORC
SCHEMBL6781436 0.86 DPP4 (0.45) CYP3A4CYP2C19KDM4EHIF1ARORC
SCHEMBL6785057 0.85 CYP19A1 (0.42) KDM4EALDH1A1MAPTHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed
EP-1310498-A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PFIZER INC. (US) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG CYP3A4 4093/4885CYP2C19 3716/4885KDM4E 1349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.